Patriot Financial Group Insurance Agency’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4
Closed -$1K 1952
2022
Q2
$1K Sell
4
-12
-75% -$3.9K ﹤0.01% 1964
2022
Q1
$7K Sell
16
-287
-95% -$112K ﹤0.01% 1517
2021
Q4
$142K Buy
303
+9
+3% +$3.87K 0.02% 549
2021
Q3
$125K Hold
294
0.02% 579
2021
Q2
$106K Hold
294
0.02% 606
2021
Q1
$83K Sell
294
-34
-10% -$9.73K 0.02% 618
2020
Q4
$93K Buy
328
+261
+390% +$73.2K 0.02% 523
2020
Q3
$18K Hold
67
0.01% 842
2020
Q2
$15K Buy
67
+2
+3% +$393 0.01% 842
2020
Q1
$10K Buy
+65
New +$10K ﹤0.01% 871
2019
Q3
Sell
-17
Closed -$2K 1485
2019
Q2
$2K Buy
17
+11
+183% +$1.3K ﹤0.01% 1155
2019
Q1
$1K Buy
+6
New +$624 ﹤0.01% 1188

Other funds holding WST

Patriot Financial Group Insurance Agency's WST Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 4 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in WST in Q1 2019 and held it in 12 quarters. The position peaked at $142K in Q4 2021. 639 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 4 West Pharmaceutical shares in Q3 2022, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in West Pharmaceutical in Q1 2019 and held it in 12 quarters.
  • Patriot Financial Group Insurance Agency's West Pharmaceutical position peaked at $142K in Q4 2021.
  • 639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.